Tomeki

Whole-body effective half-lives for radiolabeled antibodies and related issues

Whole-body effective half-lives for radiolabeled antibodies and related issues

By

0 (0 Ratings)
0 Want to read0 Currently reading0 Have read

Publish Date

1996

Publisher

Division of Regulatory Applications, Office of Nuclear Regulatory Research, U.S. Nuclear Regulatory Commission,Supt. of Docs., U.S. G.P.O. [distributor]

Language

eng

Pages

150

Description:

subjects: Radioimmunoimaging,  Monoclonal antibodies,  Radiation,  Dosage,  Radioimmunotherapy